ResearchHub Foundation(@ResearchHubF):Protection didn't require the psychedelic effect. When the authors swapped psilocybin for tabernanthalog, a non-hallucinogenic compound hitting the same receptors, the mice got similar protection against nerve loss and pain. (Heles et al., Science 2026) USC assistant professor @rust_ruslan screened psilocybin and related tryptamines for neuroprotection in stroke. See the preregistered study, the reviews, and Ruslan's updates all in the open.

2026.09.12 15:55

Protection didn't require the psychedelic effect. When the authors swapped psilocybin for tabernanthalog, a non-hallucinogenic compound hitting the same receptors, the mice got similar protection against nerve loss and pain. (Heles et al., Science 2026) USC assistant professor @rust_ruslan screened psilocybin and related tryptamines for neuroprotection in stroke. See the preregistered study, the reviews, and Ruslan's updates all in the open.

显示更多

nature@Nature

2026.09.12 07:04

Just two doses of psilocybin administered before chemotherapy completely prevented mice from developing neuropathy

转发到社区